Ivermectin and Mebendazole in Lymphoma and Leukemia: 36 Case Reports (June 2026 Update)
Medically Reviewed by: OneDayMD Editorial Team Last Updated: May 2026 Contents: Introduction Lymphoma Case Series (25 case reports) Leukemia Case Series (11 case reports) Discussion Conclusion Important Disclaimer: This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medical monitoring, as misuse can lead to serious side effects and drug interactions. Introduction Drug repurposing sits at the intersection of curiosity and caution. Ivermectin and mebendazole — long-used antiparasitic medications — have accumulated a growing body of laboratory evidence suggesting anticancer activity across multiple pathways. Meanwhile, a series of 35 reported cases involving lymphoma and leukemia patients describe tumor regression, remission, or ...